Stock Analiz

Silence Therapeutics plc (SLN) stock forecast and price target

Price $19.83 · data as of November 13, 2026

12-month price target

Average target$19.75
Upside / downside−0.4%
Analysts4
ConsensusHold
Low $19.00Average $19.75High $20.00

Gold marker: average target · white marker: today’s price ($19.83)

Analyst ratings

Strong buy 0Buy 1Hold 4Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.03+44.3%$314880
Next fiscal year
ends December 31, 2027
$-0.80+22.3%$741880
Next quarter
ends December 31, 2026
$-0.24+11.1%$4500
Quarter after
ends March 31, 2027
$-0.17—$67000

Consensus of the analysts covering Silence Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Silence Therapeutics stock price target?

The average 12-month target from 4 analysts is $19.75, 0.4% below the current price of $19.83 Targets range from $19.00 to $20.00.

Is Silence Therapeutics a buy according to analysts?

The consensus rating is “Hold” (1 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Silence Therapeutics expected to earn?

Analysts expect EPS of $-1.03 for the fiscal year ending December 31, 2026 and $-0.80 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.